25
Stories per week
2
Expert Writers
162,000
Subscribers
Daily
Frequency

Professional Audience
A global community of drug development professionals, market analysts and investors, focused on the C-suite, but broadly relevant to everyone who has a professional role or interest in drug development, primarily in the U.S., with a growing emphasis on Europe and Asia. 

Content Focus
Full spectrum clinical stage drug development, deals and data on the most compelling therapies in the pipeline, the ongoing restructuring of the industry’s R&D efforts, with a sharp focus on leadership.

Reader Demographics

Pharmaceutical - 26%
Biotech - 21%
Other - 16%
Consultant - 9%
Medical - 6%
Contract Research Organization - 6%
Medical Devices & Diagnostics - 4%
Financial - 2%
Life Sciences IT - 2%
Advertising/Marketing/Public Relations - 2%
Contract Manufacturing Organization - 2%
Government - 1%
Lab Services/Analysis/CSO - 1%
Clinical Trials - 1%
Chemicals - 1%

Manager - 26%
Staff - 21%
Director - 21%
C-Level - 21%
Pres/VP/SVP/EVP - 11%

Other - 19%
Executive Management - 14%
Marketing/Brand Management - 13%
Operations - 12%
Clinical Operations - 8%
Pharmacovigilence/Regulatory - 6%
Consultant - 6%
Business Development - 5%
Finance - 4%
Laboratory/R&D - 4%
Clinical/Preclinical Research - 2%
Engineering - 2%
Purchasing/Procurement/Acquisitions - 1%
Packaging/Logistics/Distribution - 1%
Project Management - 1%
Medical Affairs/Writing - 1%
Facility Design/Production - 1%

North America - 73%
Europe - 13%
Asia Pacific - 11%
Other - 3%